Acute response of hepatic fat content to consuming fructose or glucose alongside fat in obese and non-obese subjects

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085835" target="_blank" >RIV/00023001:_____/25:00085835 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Acute response of hepatic fat content to consuming fructose or glucose alongside fat in obese and non-obese subjects

Popis výsledku v původním jazyce

Metabolic dysfunction-associated fatty liver disease is characterized by excessive accumulation ofhepatic fat (HFC) that is increasingly being linked to excessive fructose consumption.This study included 14 non-obese subjects and 11 obese subjects. Each subject underwent twoexaminations in which liver fat (HFC0) was measured using proton (1H) MR spectroscopy (MRS). Thesubjects then consumed 150 g of fat and 50 g of glucose or fructose. The same sugar was administeredagain after 2 and 4 hours. Six hours after the first dose of sugar, a second MRS examination (HFC6) wasperformed.

Název v anglickém jazyce

Acute response of hepatic fat content to consuming fructose or glucose alongside fat in obese and non-obese subjects

Popis výsledku anglicky

Metabolic dysfunction-associated fatty liver disease is characterized by excessive accumulation ofhepatic fat (HFC) that is increasingly being linked to excessive fructose consumption.This study included 14 non-obese subjects and 11 obese subjects. Each subject underwent twoexaminations in which liver fat (HFC0) was measured using proton (1H) MR spectroscopy (MRS). Thesubjects then consumed 150 g of fat and 50 g of glucose or fructose. The same sugar was administeredagain after 2 and 4 hours. Six hours after the first dose of sugar, a second MRS examination (HFC6) wasperformed.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

<a href="/cs/project/LX22NPO5104" target="_blank" >LX22NPO5104: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů